rosiglitazone has been researched along with Adjuvant Arthritis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, H; Li, J; Li, XF; Song, B; Wang, H; Wu, S; Wu, YY; Yang, YL; Yin, SQ | 1 |
| Byun, SH; Choi, HJ; Choi, J; Choi, YS; Chung, JH; Jung, NC; Jung, SY; Kang, S; Lee, JH; Lim, DS; Seo, HG; Song, JY | 1 |
| Cho, YS; Heo, JY; Kim, CH; Song, JS | 1 |
| Britti, D; Caputi, AP; Cuzzocrea, S; De Maio, M; Di Paola, R; Dugo, L; Genovese, T; Mazzon, E; Patel, NS; Serraino, I; Thiemermann, C | 1 |
| Bianchi, A; Jouzeau, JY; Koufany, M; Moulin, D; Muresan, M; Netter, P; Sebillaud, S; Weryha, G | 1 |
| Carlberg, C; Chiesi, M; Missbach, M; Pignat, W; Spanka, C; Wiesenberg, I | 1 |
6 other study(ies) available for rosiglitazone and Adjuvant Arthritis
| Article | Year |
|---|---|
PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Fibroblasts; Humans; Inflammation; Mice; Pioglitazone; PPAR gamma; Rats; Rosiglitazone; Synovial Membrane; Synoviocytes; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2023 |
Rosiglitazone-mediated dendritic cells ameliorate collagen-induced arthritis in mice.
Topics: Animals; Arthritis, Experimental; Cells, Cultured; Coculture Techniques; Collagen; Dendritic Cells; Female; Mice; Mice, Inbred DBA; Rosiglitazone; T-Lymphocytes, Regulatory; Thiazolidinediones | 2016 |
Rosiglitazone reduces a wide range of proinflammatory profiles in synovial fibroblast SW982 under spheroid culture.
Topics: Animals; Ankle Joint; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Line; Fibroblasts; Humans; Male; Mice; Mice, Inbred DBA; Rosiglitazone; Spheroids, Cellular; Synovial Membrane; Thiazolidinediones; Treatment Outcome | 2010 |
Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
Topics: Animals; Arthritis, Experimental; Collagen Type II; Cyclooxygenase 2; Interleukin-1; Interleukin-6; Isoenzymes; Joints; Lipid Peroxidation; Mice; Mice, Inbred DBA; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha; Tyrosine; Vasodilator Agents | 2003 |
Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Topics: Adiponectin; Adipose Tissue; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Cartilage, Articular; Cytokines; Dose-Response Relationship, Drug; Fever; Fibroblast Growth Factor 2; Hindlimb; Hypoglycemic Agents; Incidence; Male; Pioglitazone; PPAR gamma; Rats; Rats, Inbred Lew; RNA, Messenger; Rosiglitazone; Synovial Membrane; Synovitis; Thiazolidinediones; Weight Gain | 2008 |
Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.
Topics: 3T3 Cells; Animals; Arthritis, Experimental; Cell Nucleus; Dexamethasone; Hypoglycemic Agents; Insulin Resistance; Leptin; Male; Mice; Proteins; Rats; Rats, Inbred Lew; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiosemicarbazones; Transcription Factors; Triglycerides | 1998 |